We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+11.78%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$2.89B
AUM Growth
+$38.7M
Cap. Flow
-$210M
Cap. Flow %
-7.28%
Top 10 Hldgs %
18.43%
Holding
453
New
33
Increased
146
Reduced
208
Closed
44

Top Buys

Rank Stock Value
1
CWK icon
Cushman & Wakefield Ltd
CWK
+$11.3M
2
MRVL icon
Marvell Technology
MRVL
+$9.6M
3
GTES icon
Gates Industrial Corporation Ltd.
GTES
+$9.54M
4
UNH icon
UnitedHealth
UNH
+$8.43M
5
DUK icon
Duke Energy
DUK
+$7.13M

Top Sells

Rank Stock Value
1
NVT icon
nVent Electric
NVT
+$12.9M
2
EXP icon
Eagle Materials
EXP
+$11.8M
3
HR icon
Healthcare Realty
HR
+$11.2M
4
ITGR icon
Integer Holdings
ITGR
+$10.8M
5
NEE icon
NextEra Energy
NEE
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Financials 14.29%
3 Healthcare 12.06%
4 Industrials 11.03%
5 Consumer Discretionary 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDYA icon
376
IDEAYA Biosciences
IDYA
$3.53B
$756K 0.03%
+17,241
New +$741K
LQDA icon
377
Liquidia Corp
LQDA
$8.06B
$750K 0.03%
50,833
-43,791
-46% -$609K
CHDN icon
378
Churchill Downs
CHDN
$6B
$743K 0.03%
6,003
+142
+2% +$17.2K
ANIP icon
379
ANI Pharmaceuticals
ANIP
$1.74B
$742K 0.03%
10,726
+254
+2% +$15.3K
AVAV icon
380
AeroVironment
AVAV
$9.56B
$739K 0.03%
4,818
+114
+2% +$15.2K
IVV icon
381
iShares Core S&P 500 ETF
IVV
$904B
$676K 0.02%
1,286
– –
IMVT icon
382
Immunovant
IMVT
$8.12B
$674K 0.02%
20,865
+495
+2% +$18.1K
DOC icon
383
Healthpeak Properties
DOC
$14.5B
$653K 0.02%
34,807
-4,363
-11% -$79.3K
FRT icon
384
Federal Realty Investment Trust
FRT
$10.2B
$651K 0.02%
6,379
-6,485
-50% -$656K
HURN icon
385
Huron Consulting
HURN
$2.44B
$643K 0.02%
6,655
-6,800
-51% -$689K
FN icon
386
Fabrinet
FN
$19.2B
$576K 0.02%
3,047
-2,205
-42% -$442K
WFRD icon
387
Weatherford International
WFRD
$6.57B
$571K 0.02%
4,950
+120
+2% +$12.2K
AXSM icon
388
Axsome Therapeutics
AXSM
$11.4B
$536K 0.02%
+6,706
New +$563K
IONS icon
389
Ionis Pharmaceuticals
IONS
$9.49B
$510K 0.02%
11,756
-1,226
-9% -$58.4K
MGNI icon
390
Magnite
MGNI
$3.48B
$490K 0.02%
+45,583
New +$455K
CTLT
391
DELISTED
CATALENT, INC.
CTLT
$482K 0.02%
8,530
+200
+2% +$10.8K
QDEL icon
392
QuidelOrtho
QDEL
$908M
$439K 0.02%
+9,157
New +$534K
CBT icon
393
Cabot Corp
CBT
$4.47B
$426K 0.01%
4,625
+108
+2% +$8.78K
WOLF icon
394
Wolfspeed
WOLF
$1.55B
$382K 0.01%
12,959
+310
+2% +$9.35K
SYNA icon
395
Synaptics
SYNA
$4.14B
$356K 0.01%
3,647
+86
+2% +$9.04K
EOLS icon
396
Evolus
EOLS
$482M
$337K 0.01%
+24,093
New +$313K
CYTK icon
397
Cytokinetics
CYTK
$10.4B
$281K 0.01%
4,013
-22,440
-85% -$1.74M
SYRE icon
398
Spyre Therapeutics
SYRE
$9.24B
$259K 0.01%
+6,835
New +$198K
DAR icon
399
Darling Ingredients
DAR
$10B
$234K 0.01%
5,023
-4,738
-49% -$209K
IWM icon
400
iShares Russell 2000 ETF
IWM
$81.4B
$202K 0.01%
+961
New +$192K
14 15
16
17 18

Similar funds

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Chartwell Investment Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Chartwell Investment Partners held 453 positions worth $2.89B, up 1.4% from $2.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Chartwell Investment Partners withdrew a net $210M in Q1 2024, closing 44 positions and reducing 208 holdings. Its most notable exit was nVent Electric, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Chartwell Investment Partners opened a new position in Cushman & Wakefield Ltd worth $11.7M.

  • Chartwell Investment Partners's largest Q1 2024 buy was Cushman & Wakefield Ltd: 1,115,950 shares worth $11.7M.
  • Chartwell Investment Partners added most to Marvell Technology in Q1 2024, an estimated $9.6M increase.
  • Chartwell Investment Partners's biggest Q1 2024 reduction was Eagle Materials, cutting an estimated $11.8M.
  • Chartwell Investment Partners fully exited nVent Electric in Q1 2024, selling an estimated $12.9M.
  • Chartwell Investment Partners's ten largest holdings make up 18% of its $2.89B portfolio in Q1 2024.
  • Chartwell Investment Partners opened 33 new positions and closed 44 in Q1 2024.
  • Chartwell Investment Partners's portfolio value rose 1.4% quarter-over-quarter to $2.89B.

Based on Chartwell Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.